Articles: 24.21 5 November 2013

Enzalutamide: new second-line treatment for prostate cancer

Enzalutamide is a new second-line treatment for castration-resistant prostate cancer. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Dr Heather Payne discusses its place in treatment.
Enzalutamide new second line treatment for prostate cancer

More details...

Latest reviews from Cochrane

In this section we present an abstract of a review relevant to prescribing in general practice from the latest issue of The Cochrane Database of Systematic Reviews. To view the article in full or for further information, visit www.thecochranelibrary.com
Atypical antipsychotics for psychoses in adolescents

More details...

Breast cancer chemoprevention: a challenge for doctors and patients

The recently updated NICE familial breast cancer guidance now recommends discussion (within specialist genetic clinics) about chemoprevention with the selective oestrogen receptor modulators (SERMs) tamoxifen and raloxifene in women at high or moderate risk of developing breast cancer in the context of alternative approaches, such …

More details...

CHART: patient data-analysis software for GP practices

CHART is a patient dataanalysis program produced by PRIMIS. Here, the authors explain what it does and how it works, and provide examples of its usage in everyday practice.
CHART patient data analysis software for GP practices

More details...

Glycopyrronium (Seebri Breezhaler): once-daily LAMA for COPD

Glycopyrronium is a new LAMA for maintenance treatment f COPD. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Dr Alice Turner discusses its place in therapy.
Glycopyrronium Seebri Breezhaler once daily LAMA for COPD

More details...

Management of lower urinary tract symptoms in BPHRecent advances in drug treatment have revolutionised

the management of patients with lower urinary tract symptoms due to benign prostatic hyperplasia. Our Drug review discusses current approaches to management followed by further sources of information and an analysis of prescription data.
Management of lower urinary tract symptoms in BPH

More details...

Propranolol might be safe in patients with stable asthma after all

In this cross-over study of patients with stable asthma, adding propranolol had negligible effects on methacholine challenge testing, quality of life or asthma severity.
Propranolol might be safe in patients with stable asthma after all

More details...

Statins: may cause diabetes but patients still better off

Professor Malik demonstrates that the risk of developing diabetes when taking statins is heavily outweighed by the observed reduction in cardiovascular events.
Statins may cause diabetes but patients still better off

More details...

The prescription charge and Hinchcliffe Committee

In our series on the history of prescribing policy, Professor Darrin Baines traces how successive governments have attempted to curb drug costs. Here, he describes the introduction of the prescription charge and the recommendations made by the Hinchcliffe Committee.
The prescription charge and Hinchcliffe Committee

More details...

Web design and marketing agency Leamington Spa